0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Brief Report: Respiratory Syncytial Virus Activity—United States, 2004-2005 FREE

JAMA. 2006;295(3):267-268. doi:10.1001/jama.295.3.267.
Text Size: A A A
Published online

MMWR. 2005;54:1259-1260

1 figure omitted

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections (LRTIs) (e.g., bronchiolitis and pneumonia) among young children, resulting in an estimated 51,000-82,000 hospitalizations annually in the United States.1 RSV also causes severe disease and death among older persons2,3 and persons of all ages with compromised respiratory, cardiac, or immune systems and can exacerbate chronic cardiac and pulmonary conditions.4,5 In temperate climates, most RSV infections occur during a distinct seasonal peak. This report presents preliminary data from RSV activity reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) for the weeks ending July 2 through December 3, 2005, indicating the onset of the 2005-06 RSV season, and summarizes trends during July 2004–June 2005. Health-care providers should consider RSV in the differential diagnosis for persons of all ages with LRTIs, implement appropriate isolation precautions to prevent nosocomial transmission,6 and provide appropriate immune prophylaxis to eligible children, including certain premature infants or infants and children with chronic lung and heart disease.7

NREVSS is a voluntary, laboratory-based surveillance system of 89 clinical and public health laboratories in 38 states and the District of Columbia.* Laboratories report weekly to CDC the number of specimens tested and the number positive for certain respiratory and enteric viruses. During July 2004–June 2005, of 135,491 tests for RSV reported, 19,642 (14.5%) were positive. Widespread RSV activity† began the week ending November 13, 2004, and continued for 21 weeks until April 2, 2005. Activity appeared highest during December for the South and Northeast, during January for the West, and during February for the Midwest (Figure). Regionally, RSV activity occurred first in the South (37 sites reporting activity; median weeks of onset and conclusion: November 2, 2004, and February 26, 2005, respectively), later in the Northeast (nine sites; November 20, 2004, and March 8, 2005) and West (19 sites; December 18, 2004, and March 26, 2005), and last in the Midwest (20 sites; January 1, 2004, and April 12, 2005). Although 94% of RSV detections were reported during the weeks ending November 13, 2004–April 2, 2005, sporadic detections were reported throughout the year. During May-October 2005, laboratories in 23 states reported RSV detections.

For the current reporting period (July 2–December 3, 2005), 84 laboratories in 38 states reported testing for RSV. Since October, 62 participating laboratories have reported RSV detections. Preliminary 2005-06 data suggest that the annual seasonal peak began in the South during the week ending October 15.

Health-care providers should consider RSV as a potential cause of acute respiratory disease among persons in all age groups during the annual seasonal peak. RSV infection is the most common cause of hospitalization for acute respiratory disease among children aged <12 months.8 RSV infection also is increasingly recognized as a cause of hospitalization among older adults.2 Laboratory testing of nasal secretions for virus or viral antigen (e.g., immunofluorescence or enzyme-linked immunosorbent assays) can be sensitive for diagnosis in infants and children aged <5 years but is less sensitive for diagnosis in older children and adults. Testing nasal secretions for viral RNA by well-designed reverse transcription-polymerase chain reaction assays can be sufficiently sensitive to detect most RSV infections in all age groups.9

No vaccine is currently available for RSV. However, infection control measures are important for preventing transmission in health-care settings.6 Infants and children at risk for serious RSV infection can receive immune prophylaxis with monthly doses of a humanized murine anti-RSV monoclonal antibody product during the RSV season.7 Infants and children at risk include (1) those aged <24 months with chronic lung disease who have required medical therapy (e.g., supplemental oxygen, bronchodilator, diuretic, or corticosteroid therapy) within 6 months of RSV season onset, (2) those with hemodynamically significant heart disease, and (3) preterm infants born at <32 weeks' gestation or preterm infants born at 32-35 weeks' gestation with at least two additional risk factors (e.g., day care attendance, exposure to environmental pollutants, school-aged siblings, congenital abnormality of the airways, or neuromuscular disease) during their first RSV season.

Because onset of RSV activity can vary among regions and communities, physicians and health-care facilities should consult their local clinical laboratories for the latest data on RSV activity.10 Additional information and updates on national and regional RSV trends are available at http://www.cdc.gov/ncidod/dvrd/revb/nrevss/index.htm.

Reported by:

National Respiratory and Enteric Virus Surveillance System collaborating laboratories. KJ Felton, AM Fry, MD, LJ Anderson, MD, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC.

*Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.

†Widespread RSV activity is defined by NREVSS as the first of 2 consecutive weeks when 50% of participating laboratories report RSV detections or isolations and when the mean percentage of specimens positive by antigen detection is >10%.

REFERENCES
Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996.  JAMA. 1999;282:1440-1446
PubMed   |  Link to Article
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;352:1749-1759
PubMed   |  Link to Article
Thompson WW, Shay DK, Weintraub E.  et al.  Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA. 2003;289:179-186
PubMed   |  Link to Article
Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.  J Pediatr. 2003;143:(5 Suppl)  S112-S117
PubMed   |  Link to Article
Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults.  Clin Microbiol Rev. 2000;13:371-384
PubMed   |  Link to Article
CDC.  Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.  MMWR. 2004;53:(No. RR-3)  1-36
Meissner HC, Long SS.American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.  Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.  Pediatrics. 2003;112:1447-1452
PubMed   |  Link to Article
Iwane MK, Edwards KM, Szilagyi PG.  et al.  Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.  Pediatrics. 2004;113:1758-1764
PubMed   |  Link to Article
Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.  J Clin Microbiol. 2003;41:4160-4165
PubMed   |  Link to Article
Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing.  Pediatr Infect Dis J. 2003;22:857-862
PubMed   |  Link to Article

Figures

Tables

References

Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996.  JAMA. 1999;282:1440-1446
PubMed   |  Link to Article
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;352:1749-1759
PubMed   |  Link to Article
Thompson WW, Shay DK, Weintraub E.  et al.  Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA. 2003;289:179-186
PubMed   |  Link to Article
Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.  J Pediatr. 2003;143:(5 Suppl)  S112-S117
PubMed   |  Link to Article
Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults.  Clin Microbiol Rev. 2000;13:371-384
PubMed   |  Link to Article
CDC.  Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.  MMWR. 2004;53:(No. RR-3)  1-36
Meissner HC, Long SS.American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.  Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.  Pediatrics. 2003;112:1447-1452
PubMed   |  Link to Article
Iwane MK, Edwards KM, Szilagyi PG.  et al.  Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.  Pediatrics. 2004;113:1758-1764
PubMed   |  Link to Article
Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.  J Clin Microbiol. 2003;41:4160-4165
PubMed   |  Link to Article
Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing.  Pediatr Infect Dis J. 2003;22:857-862
PubMed   |  Link to Article
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles